A study shed light on the side effects of mental health, narrowing down those who are genetically more vulnerable.

Researchers link GLP1 agonists to depression risk in some users and call for personalized prescribing based on genetic ...

A new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and ...

A new study raises mental health concerns about popular weight loss drugs like Ozempic and Mounjaro. These GLP-1 agonists, while effective for appetite control, may disrupt dopamine pathways linked to ...

New study finds potential link between GLP1 agonists and depression, urging further investigation into patient safety.

Vision loss, thyroid tumours, kidney problems, gallbladder issues and pancreatitis are some of the concerning side effects ...

GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...

Initially developed to manage blood sugar levels in diabetic patients, GLP-1 agonists have gained popularity for their weight-reducing effects.

Parkinson’s Disease is a neurodegenerative disorder that affected predominately the Dopamine-producing neurons in a specific ...

A groundbreaking study published in the journal Current Neuropharmacology highlights a concerning potential link between Glucagon-like Peptide-1 (GLP1) receptor agonists-widely used in blockbuster ...

Can feeling good be as easy as ordering food off a menu? A new trend suggests building a selection of dopamine hits to draw ...

Schizophrenia drug Cobenfy, a key component in Bristol Myers Squibb’s plan to navigate a transition period of major loss of ...